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Background: Angiogenesis plays a critical role in embryonic development and various physiological processes.
However, excessive angiogenesis is associated with several pathological conditions including cancer. Pithecellobium
jiringa (Jack) Prain is a traditional medicinal plant from the family Leguminosae. It is native to the Southeast Asia,
where it has been used traditionally for treatment of various ailments such as hypertension and diabetes. The
present work is aimed to study antioxidant and antiangiogenesis activities of P. jiringa ethanol extracts.
Methods: P. jiringa fruit rinds were extracted with ethanol and 50% ethanol. The antioxidant property was analysed
using, 1,1-diphenyl-2-picryl-hydrazyl free radical scavenging assay. Phytochemical analysis was performed using thin
layer chromatography and colorimetric methods. Then, cell growth inhibition was studied against a panel of
human cell lines by MTT test. In vitro inhibition of angiogenesis was studied by the following assays: isolated rat
aortic rings cell viability, colony formation, endothelial cell migration, endothelial tube formation on matrigel, and
expression of vascular endothelial growth factor by endothelial cells. In vivo antiangiogenesis effect was studied by
utilising fertilised chick embryos assay. The results were statistically analysed by analysis of variance.
Results: Ethanolic and 50% hydro-ethanolic extracts showed relatively high concentration of total phenolics
associated with potent antioxidant activity. The rat aortic rings study conducted showed potent inhibition of the
microvessels outgrowth with IC50s 5.27 ± 0.81 μg/ml (ethanolic) and 4.45 ± 0.63 μg/ml (50% hydro-ethanolic). Both
extracts arrested the growth of human endothelial cells via down-regulation of VEGF expression, leading to
inhibition of other angiogenesis cascades including migration of endothelial cells, and formation of capillary
network on matrigel matrix. The extracts also inhibited the neovascularisation of chick embryo chorioallantoic
membrane.
Conclusions: P. jiringa extracts inhibit angiogenesis by blocking the VEGF expression thus inhibiting endothelial
cells proliferation, migration and differentiation most likely due to presence of the antioxidant phenolics.
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Angiogenesis is the formation of new blood vessels
sprouting from existing vascularisation [1]. The process
plays essential role in embryonic development, wound
healing and reproductive functions. In early 1970s, it
was noted that solid tumours appear to be highly vascu-
larised [2]. It was then established that all solid tumours
are dependent on the angiogenesis in order for the* Correspondence: aminmalikshah@gmail.com
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reproduction in any medium, provided the ortumour to grow larger and metastasize [1,2]. Endothelial
cells in tumour bed tend to be more susceptible to cyto-
toxic agents due to their high proliferation rate. In
addition, endothelial cells, on the contrary to cancerous
cells, are genetically stable as they do not undergo muta-
tions and hence more sensitive to apoptotic effects of
the cytotoxic agents. Thus, these features of endothelial
cells make them a compelling target for antiangiogenesis
treatment [3]. Consequently, cytotoxic agents pose as
candidates as antiangiogenic agents on top of their po-
tent activity in causing death of cancerous cells. Pacli-
taxel, an anti-cancer drug has been shown to inhibitLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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gration and invasiveness dose-dependently both in vitro
and in vivo [3].
Extensive studies have been conducted to assess the
role of oxidative stress and hence the use of antioxidants
in the prevention of many diseases such as cancer, in-
flammation, and atherosclerosis [4-6]. In the initial stage
of these diseases, oxidative stress plays a major role in
damaging essential components of cells [4]. To date,
there have been extensive studies on natural product
compounds and extracts that showed potent antiangio-
genic activity, in conjunction to having good antioxidant
activities [7-10].
Pithecellobium jiringa (Jack) Prain is a traditional me-
dicinal plant native to the Southeast Asia which belongs
to the family Leguminosae [11]. Traditionally, a drink
mixture of pounded whole fruit with ginger is taken
daily to eliminate bladder stones [12]. The plant has
been traditionally used in treating hypertension and dia-
betes, the fruit rinds are also used for flavouring and as
fragrance in manufacturing traditional soaps, shampoos
and detergents. The matured leaves of the plant are
burnt to ashes as a cure for itchy parts of the body
[13,14]. Though there is a widespread traditional use of
the whole fruit as anti-diabetes agent, P. jiringa has not
been studied extensively [14]. This study has been
undertaken in order to investigate the antioxidant and
antiangiogenic activity of Pithecellobium jiringa ethano-
lic and 50% hydro-ethanolic extracts.
Methods
Materials
Analytical grade solvents were purchased from Avan-
tor Performance Materials (Petaling Jaya, Selangor,
Malaysia). Earles’ salt (M199) medium, trypsin, Dul-
becco’s modified eagle medium (DMEM), minimum
essential medium (MEM), fibrinogen and foetal bovine
serum were obtained from Bio-Diagnostics (Petaling Jaya,
Selangor, Malaysia). Aprotinin, L-glutamine, thrombin,
sodium chloride, fungizone, gentamycin, 6-aminocaproic
acid, suramin, dimethyl sulfoxide (DMSO), crystal violet,
phosphate buffered saline (PBS), 3-(4,5-dimethylthiazol-
2-yl-2,5-diphenyl) tetrazolium bromide (MTT), para-
formaldehyde, agarose, potassium acetate, aluminum
chloride, 1,1-diphenyl-2-picryl-hydrazyl (DPPH), quer-
cetin, gallic acid, betulinic acid, Folin-Ciocalteau re-
agent, sodium carbonate, anisaldehyde reagent, natural
product-polyethylene glycol 4000’ reagent (NP-PEG)
and Dragendorff reagent were from Sigma-Aldrich
(Subang Jaya, Selangor, Malaysia). Human umbilical
vein endothelial cells (HUVEC), hormone-dependent
breast carcinoma cells (MCF 7), human hepatocarci-
noma cells (Hep G2) and normal colonic fibroblasts
(CCD-18Co) were purchased from ATCC (Manassas,Virginia). Endothelial cell medium (ECM) was obtained
from Team Medical Scientific (Shah Alam, Selangor,
Malaysia). Matrigel matrix was purchased from Bio-
Diagnostics (Petaling Jaya, Selangor, Malaysia), and
VEGF-165 ELISA kit was obtained from Chemtron Bio-
technology Sdn Bhd (Kuala Lumpur, Malaysia). All other
chemicals used in the study were of analytical grade.
Plant material and extraction
The plant material was authenticated by the Herbarium
of School of Biological Sciences, Universiti Sains Malay-
sia, where a voucher specimen was deposited (Reference
number of 11242). The fruit rinds were separated from
the seeds and oven-dried at 40°C and powdered using a
milling machine (Retsch GmbH, Germany). Fine pow-
dered material (30 g) was macerated separately in 500
ml ethanol (EtOH) and 50% ethanol (EW) overnight at
40°C with intermittent shaking. After cooling, extracts
were filtered using Whatman filter paper No.1 (What-
man, England), concentrated at 50°C under vacuum
using a rotary evaporator (RE121 Buchi, Switzerland),
and freeze-dried using freeze-drying system (Labconco,
USA).
Experimental animals
The thoracic aortas were excised from 8 – 12 weeks old
male Sprague Dawley rats obtained from the Animal
House Facility, Universiti Sains Malaysia. The rats were
kept in well ventilated cages and allowed to free access
of tap water and normal laboratory diet. All experimen-
tal procedures were executed following the Animal
Ethics Guidelines of Universiti Sains Malaysia (USM/
Animal Ethics Approval/2011/(66)(302)).
Rat aortic ring assay
The assay was performed as previously described [15].
Briefly, aortic rings of about 1 mm thickness excised
from thoracic aortas were placed into a 48-wells plate
filled with 300 μl of serum-free M199 medium supple-
mented with 3 mg/ml fibrinogen, 5 μg/ml aprotinin and
1% L-glutamine. Thrombin (10 μl at 50 NIH U/ml in
0.15 M NaCl) was then added and incubated for 90 min
at 37°C. Subsequently, various concentrations of the
test extracts were mixed with a second layer made of
300 μl M199 medium and containing 1% L-glutamine,
2.5 μg/ml fungizone, 60 μg/ml gentamycin, 0.1% 6-
aminocaproic acid and 20% heat inactivated foetal bo-
vine serum (HIFBS), and were added into each well.
Suramin and 1% DMSO were used as positive and
negative control respectively. The plate was incubated
at 37°C in a humidified CO2 incubator. The second
layer was replaced with a freshly prepared one con-
taining the respective tested extracts on day 4. On
day 5, the explants were visualised and photographed
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nification. The blood vessels outgrowth of an explant was
quantified by using Leica QWin computerised imaging
software [16].
Cell viability assay
Inhibition of cell growth was evaluated by the MTT test.
The cells were treated with extracts as well as 1% DMSO
as a negative control for 48 h. Cell viability was then
assessed following a previously described method [17].
The absorbance of the treated cells was then taken by
using a microtitre plate reader (Tecan, Austria) at 570
nm. The results are presented as average percentage of
cell viability to that of the negative control.
Colony formation assay
The colony formation assay was conducted following a
previously described method [18]. Single cell suspension
of HUVEC cells was seeded at 500 cells/ml in a 6-well
plate and incubated for 24 h to allow attachment. Subse-
quently, culture medium containing various concentra-
tions of the test extracts was added; betulinic acid at 20
μg/ml was used as a positive control and 1% DMSO
served as a negative control. After a 48 h treatment, the
medium was discarded, the cells were washed by PBS,
and a fresh medium was added. On the sixth day of in-
cubation, the cells were fixed with 4% (v/v) paraformal-
dehyde and subsequently stained with 0.2% (w/v) crystal
violet solution in PBS. Colonies consisting of more than
50 cells were counted by using a stereomicroscope, and
the results are reported as a mean percentage of survival
fraction ± SD (n=2).
Cell migration assay
Cell migration was performed following previously
described procedures [19]. In brief, HUVEC cells were
seeded in a 6-well plate until a confluent monolayer was
formed. Subsequently, a wound was created using a ster-
ile 200 μl micropipette tip. The detached cells were
removed by washing with PBS and the plates were then
treated with the test extracts at 0.5 μg/ml. The wounds
were photographed after 12 and 18 h, and the width of
the wound was measured using Leica QWin imaging
system; 10 fields per well were taken and a minimum of
30 readings per field were measured. The results are pre-
sented as a mean percentage of migration inhibition in
comparison to control ± SD (n=3).
Tube formation assay on matrigel matrix
The matrigel matrix (5 mg/ml) was obtained by diluting
the stock at 1:1 with serum-free medium, before 300 μl
of the solution was transferred into each well of a 48-
well plate. The matrix was allowed to solidify at 37°C
and 5% CO2 for 45 min. The HUVEC cells were thentrypsinized and seeded (3 × 104cells/well) in 100 μl fresh
medium containing various concentrations of the test
extracts. After 6 h incubation, the tubular structures
were visualised and photographed under an inverted
light microscope at 4× magnification (Olympus, Japan).
Quantitative assessment of the tube formation inhibition
was carried out by using the ImageJ Software by measur-
ing the area of the tubular structures [20]. The results
are presented as a mean percentage inhibition ± SD
(n=3).
VEGF concentration in HUVEC cells lysates
The VEGF concentration was determined by using a
human VEGF-165 ELISA kit (Raybio, USA) following
the manufacturer’s protocols. HUVEC cells were treated
with the test extracts at 2.5 μg/ml for 24 h before the
cell lysates were prepared using cell lysis buffer provided
with the kit. A calibration curve of VEGF standard was
prepared at the same time. Subsequently, the concentra-
tion of VEGF in cell lysates was quantified using the log-
log regression equation of the standard calibration curve
(y = 0.0099x0.6137, R2 = 0.996). The experiment was
repeated two times in triplicates.
In vivo chorioallantoic membrane assay
The in vivo antiangiogenic effect of the test extracts was
investigated by CAM assay as described previously [21].
Fertilized chicken eggs of 5-days old were obtained from
a local hatchery. Albumin (5 ml) was withdrawn and the
eggs were incubated horizontally to allow the CAM de-
tachment of the shell. The extracts were dissolved in
ethanol and prepared as agarose discs of 1.2% at extracts
concentration of 25 and 50 μg/disc. Discs contained the
vehicle only (ethanol) were used as negative control. A
small window was made on the shell through which the
discs were applied to the CAM. The window was closed
back and sealed with a sterile surgical tape and the eggs
were incubated for another 24 h. The images of each
treated CAM were captured under dissecting micro-
scope. The blood vessels in the disc application site were
counted to calculate the percentage inhibition [22].
DPPH scavenging activity
The free radical scavenging activity of the test extracts
was assessed by 1,1-diphenyl-2-picryl-hydrazyl (DPPH)
[23]. The assay was done in a 96-well microplate. Briefly,
100 μl of extracts (1.5625 - 100 μg/ml) and gallic acid as
the standard (0.3125 - 20 μg/ml) prepared in methanol
were loaded into the wells. Then, 100 μl of 200 μM
DPPH solution in methanol was added. After 30 min of
incubation at room temperature (RT), the absorbance
was measured at 517 nm using a microplate reader
(Tecan, Austria) against methanol as a blank. The nega-
tive control was made of 100 μl methanol and 100 μl of
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cated higher free radical scavenging activity. The free
radical scavenging activity of the extracts and gallic acid
was determined as follows:
Percentage of free radical scavenging activity = [1 −
(AS −AB)/AC −AB] × 100, where:
AS: absorbance of sample/standard
AB: absorbance of blank
AC: absorbance of controlPhytochemical screening
P. jiringa fruit rinds extracts were screened for presence
of various classes of chemical constituents as previously
described [24]. High performance thin layer chromatog-
raphy (HPTLC) (Camag, Switzerland) was conducted
using a mobile phase system of ethyl acetate-formic
acid-acetic acid-water (100:11:11:26). The developed
TLC plates were then sprayed with various spraying
reagents as the following; anisaldehyde reagent for terpe-
noids, natural product reagent for flavonoids, Dragen-
dorff reagent for alkaloids and Folin-Ciocalteu reagent
for phenolic compounds. After spraying, the plates were
heated at 100°C for 5 min, and were visualised at 366
nm. The presence of the compounds was confirmed by
the presence of bands after spraying with respective
reagents. All tests were repeated thrice.Estimation of total phenolics content
The total phenolics content was determined using a col-
orimetric assay [25]. Test extracts (100 μl at 1 mg/ml in
methanol) was added to 750 μl Folin-Ciocalteau reagent
(diluted 1:10 with deionised water) and incubated for 5
min in the dark at RT. Then, 750 μl of 60 g/l sodium bi-
carbonate solution was added and further incubated in
the dark for 90 min at 30°C. The absorbance was read at
725 nm. Gallic acid was used as the standard reference
(50–1600 μg/ml). The results are expressed as mg gallic
acid equivalents per gram of the extract.Total flavonoids content
The total flavonoids content was determined using as
previously described [26]. Quercetin (3.91 - 250 μg/ml
in methanol) was used as a standard reference. The
standard and the extracts solutions (500 μl) were mixed
with 0.1 ml of 10% (w/v) aluminum chloride, 0.1 ml of
1M potassium acetate, 1.5 ml methanol and 2.8 ml
water. As for the blank, both potassium acetate and
aluminum chloride were not added and their volume
was replaced by water. The reaction mixture was incu-
bated for 30 min at RT and the absorbance was taken at
415 nm.Statistical analysis
Statistical analysis was carried out using SPSS software
version 16.0 (SPSS, Chicago, Illinois). All values are
shown as a mean ± SD. Comparisons among multiple
groups were done via analysis of variance (ANOVA),
P < 0.05 was considered significant.
Results
Rat aortic ring assay
The antiangiogenic effect of EtOH and EW extracts was
first investigated using the rat aortic ring model.
Figure 1A show the microvessels outgrowth from the
untreated aortic rings. Figures 1B, 1C and 1D show re-
duction in the microvessels outgrowth by both extracts
(10 μg/ml) as well as Suramin (100 μg/ml) as a positive
control. IC50s were calculated from the dose response
curves (Figure 1E (i) and (ii)) and were found to be
5.27 ± 0.81 μg/ml and 4.45 ± 0.63 μg/ml for EtOH and
EW extracts, respectively. Suramin, as a positive control,
showed almost 100% inhibition of the microvessels out-
growth at 100 μg/ml.
Effect of EtOH and EW extracts on HUVEC cells
proliferation
Cytotoxic effect of both extracts was assessed by MTT
test on HUVEC cells, revealing a selective cytotoxicity
towards the endothelial cells with IC50 0.60 ± 0.15 μg/ml
(EtOH extract) and 3.01 ± 0.05 μg/ml (EW extract). The
extracts’ cytotoxicity was also tested on MCF 7 (breast
cancer cell line), Hep G2 (liver cancer cell line), and
CCD-18Co (normal colonic fibroblasts). However, the
extracts showed lower growth inhibition towards these
cell lines. Table 1 depicts the calculated half maximal in-
hibitory concentration (IC50s) on all tested cell lines.
Inhibition of colony formation
In order to figure out whether the extracts exhibit cyto-
toxic or cytostatic effect on HUVEC cells, the colony
formation assay was performed. The results indicate that
both extracts are cytostatic as shown by the percentage
of survival cells [27]. The plating efficiency (PE) was
13.7 ± 1.00%. The IC50s were 2.32 ± 0.28 μg/ml (EtOH
extract) and 6.24 ± 0.54 μg/ml (EW extract). Figure 2
describes the survival percentages of HUVEC cells after
treatment with the test extracts and their colonies after
treatment.
Cell migration
To understand the effect of EW and EtOH extracts on
HUVEC cells migration, which is one of the fundamen-
tal tools in many pathological aspects, the scratch
wound healing assay was performed. Upon scratching
the HUVEC cells monolayer, activated motile endothelial
cells move randomly in direction of the angiogenic
Figure 1 Effect of P. jiringa fruit rinds extracts on microvessels
outgrowth in rat aortic rings. The rings were treated with (A) 1%
DMSO, (B) 10 μg/ml EtOH extract, (C) 10 μg/ml EW extract and (D)
100 μg/ml suramin as a positive control. (E) Dose dependent
relationship of the (i) EtOH and (ii) EW extracts on the microvessels
outgrowth of the explants. The data was represented as means of
three experiments (n=3), error bars equal ± SD. *P < 0.05, ** P <0.01
and *** P < 0.001.
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the results demonstrated effective reduction in the mi-
gratory capacity of the extracts-treated cells as compared
to their untreated counterparts (Figure 3). In EW
extract-treated cells at 0.5 μg/ml, the percentage of wound
closure at 12 and 18 h was 48.02 ± 1.94% (P = 0.002) and
72.90 ± 0.9%, respectively. At the same concentration of the
EtOH extract, the percentage of wound closure was 41.13 ±
4.38% and 49.50 ± 1.39% at 12 and 18 h, respectively.
Tube formation
Under normal culture conditions endothelial cells cul-
tured on a matrigel matrix form tube-like structures
within 6 h. Treatment of HUVEC cells with EtOH and
EW extracts has reduced the formation of the tube-like
structures in a dose dependent manner (Figure 4). The
extracts showed IC50s of 3.62 ± 0.83 μg/ml (EtOH) and
2.19 ± 0.19 μg/ml (EW). The positive control (suramin)
inhibited endothelial tube formation by 97 ± 0.72% at
100 μg/ml.
Inhibition of VEGF expression
The inhibitory effect of the extracts on VEGF expression
was determined by quantifying VEGF 165 concentration
in lysates of endothelial cells. The results showed that
both extracts caused significant inhibition of VEGF ex-
pression in HUVEC cells. The VEGF concentration in
cell lysates in cells treated with EtOH extract at 2.5 μg/
ml (57.77 ± 4.65 pg/ml) (P = 0.004) and EW extract
(69.06 ± 3.71 pg/ml) (P < 0.007) was significantly lower
than that measured in untreated cells (253.36 ± 8.19 pg/
ml) (P = 0.01). Hence, the present results propose for
down-regulation of VEGF expression as one of the
mechanism of actions involved.
In vivo inhibition of CAM neovascularisation
Inhibition of normal vascularisation in chick embryo
was observed by the treatment of the CAM with 25 andTable 1 IC50 values (μg/ml) of EtOH and EW extracts on
different human cell lines
Extract HUVEC MCF 7 Hep G2 CCD-18Co
EtOH 0.60 ± 0.15 28.66 ± 1.86 40.63 ± 0.63 4.24 ± 0.15
EW 3.01 ± 0.05 101.34 ± 1.51 38.58 ± 0.66 11.50 ± 1.02
Figure 2 Effect of P. jiringa fruit rinds extracts on clonogenicity
of HUVEC cells. (A) Effect of EtOH extract and EW extract. (B) The
clonogenicity of the cells in 6-well plates after treatment with the
extracts and controls. The clonogenic cell survival of HUVEC cells
treated with: (−) 1% DMSO as negative control, (+) betulinic acid 20
μg/ml as positive control and indicated concentrations of the
extracts (μg/ml). Values are means of two experiments, error bars
equal ± SD. Plating efficiency was 13.7 ± 1.00%. *P < 0.05, **P < 0.01
and ***P < 0.001, comparing to control.
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normal vascularisation in the untreated CAM which
consisted of primary, secondary and tertiary microves-
sels. In comparison, the CAM treated with 25 and 50 μg
of EtOH and EW extracts displayed distorted vascular-
isation as well as perturbation on existing vasculatures
(Figure 5A1 and 5A2; Figure 5B1 and 5B2). The percent-
age nhibition in EtOH extract treated CAMs was
32.75 ± 5.59% (25 μg) (P = 0.01) and 62.56 ± 4.20% (50 μg)
while that in EW extract treatment was 51.30 ± 6.50%
(25 μg) and 71.11 ± 3.08% (50 μg).
DPPH scavenging activity
The results showed that the extracts possess potent
scavenging capacity of the stable free radical DPPH. EWextract was more effective free radical scavenging agent
with IC50 18.48 ± 1.60 μg/ml than the EtOH extract
which showed an IC50 of 33.52 ± 2.05 μg/ml.
Phytochemical analysis
The preliminary phytochemical analysis revealed the
presence of phenolics, flavonoids, terpenoids and alka-
loids in both extracts. The TLC plates which were
sprayed with the natural product reagent and enhanced
with 5% ethanolic PEG 4000’ showed presence of differ-
ent flavonoid compounds. Appearance of blue bands
indicates the presence of phenolic acids; yellow-orange
bands indicate the presence of flavonols and yellow-
green bands indicate flavones.
Spraying with Folin-Ciocalteu reagent and enhancing
with 20% sodium carbonate solution has marked the
presence of phenolic compounds in all extracts, indi-
cated by appearance of dark blue bands. Spraying the
TLC plates with anisaldehyde reagent indicate the pres-
ence terpenoids in both extracts, as indicated by the
deep purple bands, however with higher band intensity
in EtOH extract than in EW extract. Presence of alka-
loids was also noted in both extracts, as shown by the
presence of brown bands upon spraying with Dragen-
dorff reagent. From these results, it can be seen that P.
jiringa extracts contain abundant number of phyto-
constituents which may contribute to various pharmaco-
logical activities.
Total phenolics and total flavonoids
The EtOH and EW extracts were subjected to a quanti-
tative analysis of total phenolics and flavonoids. In gen-
eral, EW and EtOH extracts has showed relatively
similar amount of total phenolics and flavonoids. EtOH
extract contained 143.95 ± 0.22 mg/g total phenolics
and 2.21 ± 0.17 mg/g of total flavonoids while EW ex-
tract contained 146.22 ± 1.17 mg/g total phenolics and
2.84 ± 0.83 mg/g total flavonoids.
Discussion
Plants contain tremendous amount of phytochemical
constituents such as phenolics and flavonoids com-
pounds, these have a great potential in promoting and
maintaining a good health [28]. Antioxidants from plant
origin have always been tagged with possibilities in treat-
ing and lowering the risk of various diseases such as in-
flammation and cancer [4]. Antioxidants have the ability
to scavenge reactive oxygen species that may cause damage
to DNA, proteins and lipids. In addition, antioxidants may
suppress cancer cells through affecting cyclooxygenase-
2 enzyme or inhibiting oncogene expression [28].
Phytochemical analysis of both EtOH and EW extracts
of P. jiringa fruit rinds revealed the presence of various
secondary metabolites including phenolics, flavonoids,
Figure 3 Effect of P. jiringa fruit rinds extracts on HUVEC cells migration. Upon creation of the wound, the cells were treated with 0.5 μg/ml
of the extracts and 1% DMSO (vehicle) for 12 and 18 h. (A) EtOH extract and (B) EW extract.
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previous GC-MS-TOF analysis of P. jiringa seeds extracts
prepared by carbon dioxide supercritical extraction has
shown the presence of flavonoids, terpenoids, alkaloids,
vitamin E, allyl sulphur and some fatty acids [13,14].
EW extract showed higher potency in scavenging the
DPPH free radicals than EtOH extract. Significant rela-
tionship between elevated antioxidant activities with
high amount of total phenolics content has been exten-
sively discussed [29-31]. Generally, the antioxidant activ-
ity of phenolics is greatly contributed by their structures,
stressing on the presence of hydrogen-donating hydroxyl
groups, and those with more hydroxyl groups possess
greater antioxidant capacity [29]. Several studies have
shown anti-mutagenic and anti-carcinogenesis effects of
phenolic acids such as chlorogenic and caffeic acids
due to their high antioxidant effect [31]. Previously,
methanolic extract of P. jiringa seeds was found to
inhibit Epstein-Barr Virus (EBV) activation in Rajicells, a model of anti-tumour screening, indicating the
potential anti-cancer effect of P. jiringa [32]. The
present study found relatively high concentration of
total phenolics in both extracts and potent antioxidant
activity which suggests a possible chemopreventive
effect.
Angiogenesis is essential in tumour growth and metas-
tasis as the process provides necessary oxygen and nutri-
tion for the growing tumour [2]. Our results showed
that both EtOH and EW extracts potently inhibited the
outgrowth of new blood vessels in the rat aortic rings in
a dose-dependent manner. At the same time the extracts
showed selective anti-proliferative effect towards the
endothelial cells compared to other human cancer cell
lines. The colony formation assay was then performed in
order to make distinction between cytotoxic and cyto-
static response. The results indicate that EtOH and EW
extracts have cytostatic effect on HUVEC cells as shown
by gradual decrease in the cell survival percentage after
Figure 4 Effect of P. jiringa fruit rinds extracts on tube-like formation in HUVEC cells. (A) Effect of EtOH extract, (B) EW extract and (C)
dose dependent relationship of the extract on the tube formation. The cells were treated with (1) 1% DMSO, (2) 0.625 μg/ml, (3) 1.25 μg/ml, (4)
2.5 μg/ml, (5) 5 μg/ml of extracts and (6) 100 μg/ml of Suramin. The dose dependent effect of the extracts is presented as mean ± SD, *P < 0.05,
and ***P < 0.001.
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fect may be explained due to the cytostatic effect on
HUVEC cells particularly at low concentration of the
extracts.
Collectively, the anti-proliferation and rat aortic ring
assay results indicate that the antiangiogenic effect of
the extracts is due to the selective inhibition of the
growth of the endothelial cells. During degradation of
the vascular basement membrane and extracellular
matrix, activated endothelial cells migrate into the peri-
vascular space, differentiate and form capillary network
[33]. The significant inhibition of endothelial cells migra-
tion at low extract concentration (0.5 μg/ml) and the in-
hibition differentiation of endothelial cells on matrigelindicate these steps in the angiogenesis cascade as pos-
sible targets of the P. jiringa active principles.
In order to get deeper insights into the mechanism
of the antiangiogenic activity of the extracts, the effect
on the VEGF expression in endothelial cells was inves-
tigated. Vascular endothelial growth factor (VEGF)
plays a crucial role in regulation of angiogenesis such
as proliferation, migration and survival of endothelial
cells. The results showed that VEGF expression has
been significantly reduced in both extracts at subcyto-
toxic concentration of 2.5 μg/ml (P < 0.01), proposing
for down-regulation of VEGF expression as the mech-
anism of action involved in inhibiting the angiogenesis
cascade. Overexpression of VEGF contributes to cancer
Figure 5 Effects of P jiringa fruit rind extracts on
neovascularisation in chick chorioallantoic membrane. (A) CAM
treated with EtOH extract and (B) EW extract. The CAMs were
treated with (1) 25 μg (2) 50 μg extracts and (C) 1% EtOH.
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may provide a new source of VEGF inhibitors as anti-
tumour candidates.
In order to confirm that the antiangiogenic effect of P.
jiringa extracts is reproduced in vivo, CAM assay was
conducted. Treatment of the CAMs with either the
EtOH or EW extracts changed the vascularisation pat-
tern; both extracts inhibited the new blood vessels for-
mation in the treated CAMs as well as distortion of
existing vasculature. This result further supports the
antiangiogenic activity of P. jiringa.
Conclusions
The present study reports for the first time the inhib-
ition of angiogenesis by P. jiringa extracts by blocking
the VEGF expression leading to inhibition of endothelial
cell proliferation, migration, and differentiation into a
functional capillary network on matrigel matrix. This
plant may provide a new source of antiangiogenesisagents which can be considered as potential candidates
in the treatment of angiogenesis related diseases such as
cancer, psoriasis, rheumatoid arthritis and diabetic
retinopathy.
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